Enzyme clue may unlock new lewy body dementia treatments
NCT ID NCT05304195
First seen Nov 20, 2025 · Last updated May 05, 2026 · Updated 20 times
Summary
This study is checking whether people with Lewy body dementia have lower activity of a key brain enzyme called glucocerebrosidase. Researchers will compare enzyme levels in 236 participants (patients and healthy volunteers) to see if a drop in activity is linked to the disease. If so, existing treatments for Gaucher disease might be tested for dementia in the future.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DEMENTIA WITH LEWY BODIES are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Centre de neurologie Cognitive
RECRUITINGParis, France, 75010, France
Contact
Conditions
Explore the condition pages connected to this study.